Effect of combined inhaled corticosteroid-formoterol therapy on short-acting beta2-agonist use in Poland: a retrospective analysis of pharmacy reports

R. Dobek (Warsaw, Poland), W. Barg (Wroclaw, Poland), G. Bochenek (Kraków, Poland), G. Brozek (Katowice, Poland), D. Brzostek (Warsaw, Poland), P. Dabrowiecki (Warsaw, Poland), A. Dabrowski (Warsaw, Poland), R. Gawlik (Katowice, Poland), A. Kucharczyk (Warsaw, Poland), I. Kuprys-Lipinska (Lodz, Poland), A. Mastalerz-Migas (Wroclaw, Poland), E. Zagrajek (Warsaw, Poland), M. Kowalski (Lodz, Poland)

Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Session: Clinical and laboratory pharmacology in asthma
Session type: E-poster session
Number: 1411
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Dobek (Warsaw, Poland), W. Barg (Wroclaw, Poland), G. Bochenek (Kraków, Poland), G. Brozek (Katowice, Poland), D. Brzostek (Warsaw, Poland), P. Dabrowiecki (Warsaw, Poland), A. Dabrowski (Warsaw, Poland), R. Gawlik (Katowice, Poland), A. Kucharczyk (Warsaw, Poland), I. Kuprys-Lipinska (Lodz, Poland), A. Mastalerz-Migas (Wroclaw, Poland), E. Zagrajek (Warsaw, Poland), M. Kowalski (Lodz, Poland). Effect of combined inhaled corticosteroid-formoterol therapy on short-acting beta2-agonist use in Poland: a retrospective analysis of pharmacy reports. 1411

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: